Correlation Between Lucid Diagnostics and Pressure Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lucid Diagnostics and Pressure Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lucid Diagnostics and Pressure Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lucid Diagnostics and Pressure Biosciences, you can compare the effects of market volatilities on Lucid Diagnostics and Pressure Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lucid Diagnostics with a short position of Pressure Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lucid Diagnostics and Pressure Biosciences.

Diversification Opportunities for Lucid Diagnostics and Pressure Biosciences

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Lucid and Pressure is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Lucid Diagnostics and Pressure Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pressure Biosciences and Lucid Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lucid Diagnostics are associated (or correlated) with Pressure Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pressure Biosciences has no effect on the direction of Lucid Diagnostics i.e., Lucid Diagnostics and Pressure Biosciences go up and down completely randomly.

Pair Corralation between Lucid Diagnostics and Pressure Biosciences

If you would invest  92.00  in Lucid Diagnostics on September 2, 2024 and sell it today you would earn a total of  8.00  from holding Lucid Diagnostics or generate 8.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy4.76%
ValuesDaily Returns

Lucid Diagnostics  vs.  Pressure Biosciences

 Performance 
       Timeline  
Lucid Diagnostics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Pressure Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pressure Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Pressure Biosciences is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Lucid Diagnostics and Pressure Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lucid Diagnostics and Pressure Biosciences

The main advantage of trading using opposite Lucid Diagnostics and Pressure Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lucid Diagnostics position performs unexpectedly, Pressure Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will offset losses from the drop in Pressure Biosciences' long position.
The idea behind Lucid Diagnostics and Pressure Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years